When hackers gained access to the personal information of roughly 5 million Australians during the 2025 cyberattack on Qantas, the obvious question was whether the airline had failed in its legal duty to protect that data. After nearly a year of preliminary inquiries, Australia's privacy regulator has answered that question, at least for now.
Laboratory testing is supposed to answer a medical question. The Justice Department says one of Labcorp's testing panels answered another as well: how to bill Medicare. The laboratory diagnostics company has agreed to pay $14.5 million to resolve allegations that it submitted false claims to Medicare Part B for medically unnecessary urine drug testing performed through a panel marketed as ToxAssure Comprehensive.
Austria's highest administrative court has brought one of the country's most closely watched data protection cases to a close, confirming that the creation and commercial use of inferred political preferences for millions of people violated the General Data Protection Regulation and clarifying several principles that will shape how GDPR fines are assessed in the years ahead.
The Financial Reporting Council has again found itself scrutinizing PwC's work on Babcock International, but this time the focus is on a different set of audits and a different engagement partner. The conclusion, however, is familiar. After a separate investigation into the company's statutory audits for the financial years ending March 31, 2019, and March 31, 2020, the UK audit regulator has imposed a £3.25 million financial penalty on the firm, concluding that the quality of the audits fell below the standard expected of statutory auditors.
The legal fallout from 23andMe's 2023 data breach is now colliding with the company's bankruptcy proceedings. A coalition of 42 state attorneys general announced Tuesday that it has reached an $18 million settlement with the bankruptcy trustee for 23andMe, resolving allegations that the genetic testing company failed to implement reasonable safeguards before a breach that exposed the information of 6.9 million customers worldwide.
A bipartisan coalition of 49 attorneys general has secured more than $29 million from Glenmark Pharmaceuticals to resolve allegations that the company participated in a long-running scheme to inflate the prices of generic prescription drugs, New York Attorney General Letitia James announced Wednesday.
The Canadian Securities Administrators did not set out to measure how many firms had suffered cyber incidents. Instead, it examined something more revealing: whether the safeguards meant to prevent those incidents were keeping pace with the way financial firms now operate.